LUMI实验室:基于基础模型驱动的自主平台,助力发现用于mRNA递送的可离子化脂质设计方案
LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery
生物技术与制药领域的最新动态
LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery
Editing strigolactone hormone receptor for robust antiviral silencing in rice
A regulatory network promotes apoplastic alkalinization to prime plant immunity in tissues distal to site of infection
Fungal-derived cellobiose metabolic pathway fuels T cells to bypass intratumoral glucose competition
ARPA-H designates up to $144M for anti-aging medical research
Worried Trump's MFN push will ‘destroy biotech innovation,’ midsize companies form coalition to fight back
Charles River sells manufacturing and discovery businesses to fulfill promised pivot
Appointments and advancements for Feb. 25, 2026
Financings for Feb. 25, 2026
In the clinic for Feb. 25, 2026
Other news to note for Feb. 25, 2026
Regulatory actions for Feb. 25, 2026
Alkermes’ Richard Pops to step down after three-decade run as CEO
Charles River sells its CDMO and European discovery businesses
Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess
After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
Accent axes a cancer study; Werewolf considers its options
Alkermes CEO Richard Pops to retire after 35-year tenure
States sue Kennedy over US childhood vaccine overhaul
GSK to acquire 35Pharma in $950M deal for cardiovascular drug